Related Experiment Videos
Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol.
Hesham Al-Inany1, Mohamed A Aboulghar, Ragaa T Mansour
1The Egyptian IVF-ET Centre, Maadi, Cairo, Egypt. kaainih@link.net
Reproductive Biomedicine Online
|June 14, 2005
Summary
Flexible gonadotrophin-releasing hormone (GnRH) antagonist administration did not significantly change pregnancy rates compared to fixed protocols. However, the flexible approach reduced medication costs by lowering gonadotrophin and antagonist usage.
Area of Science:
- Reproductive Endocrinology
- Infertility Treatment
- Clinical Trial Analysis
Background:
- Optimizing controlled ovarian stimulation protocols is crucial in assisted reproductive technologies.
- Gonadotrophin-releasing hormone (GnRH) antagonists are widely used to prevent premature luteinizing hormone surges.
- Flexible versus fixed administration protocols for GnRH antagonists are debated for efficacy and cost-effectiveness.
Purpose of the Study:
- To compare the efficacy and resource utilization of flexible versus fixed GnRH antagonist administration protocols.
- To determine if flexible GnRH antagonist administration, based on follicular size, improves pregnancy rates.
- To evaluate medication requirements in flexible versus fixed GnRH antagonist protocols.
Main Methods:
- A meta-analysis of randomized controlled trials (RCTs) was performed.
- A comprehensive literature search identified relevant studies.
- Data from four eligible RCTs were analyzed using RevMan software.
Main Results:
- No statistically significant difference in pregnancy rates was observed between flexible and fixed GnRH antagonist protocols.
- A trend towards higher pregnancy rates was noted with fixed protocols, particularly when administration was delayed beyond day 8.
- Flexible protocols resulted in a significant reduction in the number of antagonist ampoules and the amount of gonadotrophin used.
Conclusions:
- Flexible and fixed GnRH antagonist administration protocols show comparable pregnancy rates in assisted reproduction.
- Flexible protocols offer a significant advantage in reducing medication costs, specifically recombinant follicle-stimulating hormone (FSH).
- Further research may explore optimal timing for fixed protocols to potentially enhance pregnancy outcomes.